Synergy CHC Stock Forecast, Price & News

0.00 (0.00 %)
(As of 09/22/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Average Volume43,153 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SNYR News and Ratings via Email

Sign-up to receive the latest news and ratings for Synergy CHC and its competitors with MarketBeat's FREE daily newsletter.

Synergy CHC logo

About Synergy CHC

Synergy CHC Corp., a consumer health care company, markets and distributes various consumer branded products primarily in the health and wellness industry in North America. The company offers FOCUSfactor, a brain-health nutritional supplement that includes a blend of brain supporting vitamins, minerals, antioxidants, and other nutrients; Flat Tummy Tea, a two-step herbal detox tea that works to help speed metabolism, boost energy, and reduce bloating; and Hand MD, an anti-aging skincare line formulated for the hands. It also provides Neuragen, a topical product that works directly at the site of the pain as opposed to oral products; Sneaky Vaunt, a backless, strapless, stick on, and push up bra; The Queen Pegasus, a two-step eyelash elixir kit for natural eyelashes; Per-fekt Beauty line of cosmetics; and Think Fuel, a nootropic supplement for enhance brain function, and sells its products directly to wholesalers and distributors; and online through flattummyco.com, sneakyvaunt.com, thequeenpegasus.com, perfektbeauty.com, and www.thinkfuel.com, as well as through retail distribution channels. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.


Synergy CHC Corp.
Synergy CHC Corp.
August 25, 2021 |  barrons.com
News for Synergy CHC Corp
News for Synergy CHC Corp
December 24, 2020 |  markets.businessinsider.com
Synergy CHC Corp. Announces First Quarter 2020 Results
Synergy CHC Corp. Announces First Quarter 2020 Results
June 29, 2020 |  finance.yahoo.com
Synergy CHC Corp. Announces Third Quarter 2019 Results
Synergy CHC Corp. Announces Third Quarter 2019 Results
November 14, 2019 |  finance.yahoo.com
Synergy CHC Corp. Announces Second Quarter 2019 Results
Synergy CHC Corp. Announces Second Quarter 2019 Results
August 13, 2019 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.99 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Synergy CHC (OTCMKTS:SNYR) Frequently Asked Questions

What stocks does MarketBeat like better than Synergy CHC?

Wall Street analysts have given Synergy CHC a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Synergy CHC wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has Synergy CHC's stock been impacted by Coronavirus (COVID-19)?

Synergy CHC's stock was trading at $0.0650 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, SNYR stock has decreased by 7.7% and is now trading at $0.06.
View which stocks have been most impacted by COVID-19

Who are Synergy CHC's key executives?

Synergy CHC's management team includes the following people:
  • Jack Ross, Chairman, President, CEO & Chief Financial Officer
  • Jaime Fickett, Senior Vice President-Finance & Operations
  • Johannes Weirather, Chief Digital Officer-The Synergy Effect
  • Andy Davies, Chief Operating Officer-The Synergy Effect
  • Alfred Baumeler, Executive Vice President-Sales & Marketing Retail

Who are some of Synergy CHC's key competitors?

What other stocks do shareholders of Synergy CHC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Synergy CHC investors own include Guardion Health Sciences (GHSI), ETFMG Alternative Harvest ETF (MJ), Hemp (HEMP) and Biopharmx (BPMX).

What is Synergy CHC's stock symbol?

Synergy CHC trades on the OTCMKTS under the ticker symbol "SNYR."

How do I buy shares of Synergy CHC?

Shares of SNYR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Synergy CHC's stock price today?

One share of SNYR stock can currently be purchased for approximately $0.06.

How many employees does Synergy CHC have?

Synergy CHC employs 36 workers across the globe.

What is Synergy CHC's official website?

The official website for Synergy CHC is www.synergychc.com.

How can I contact Synergy CHC?

The company can be reached via phone at (615) 939-9004.

This page was last updated on 9/23/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.